US Patent 8221765 Multivalent fibronectin based scaffold domain proteins
Patent 8221765 was granted and assigned to Bristol-Myers Squibb on July, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+483 characters)
Article
Patent abstract
The present invention relates to multivalent polypeptides comprising at least two fibronectin scaffold domains connected via a polypeptide linker. The invention also relates to multivalent polypeptides for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Eric Furfine0
H. Nicholas Marsh0
Irvith M. Carvajal0
Joan Carboni0
Marco Gottardis0
Ray Camphausen0
Ricardo Attar0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08221765 Multivalent fibronectin based scaffold domain proteins US Patent 8221765 Multivalent fibronectin based scaffold domain proteins
Infobox
Patent Number
08221765
Patent Number
8221765
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08221765 Multivalent fibronectin based scaffold domain proteins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08221765
Date of patent
July 17, 2012
Patent application number
12470989
Date Filed
May 22, 2009
Patent primary examiner
Find more entities like US Patent 8221765 Multivalent fibronectin based scaffold domain proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
